デフォルト表紙
市場調査レポート
商品コード
1242135

細胞シグナル伝達の世界市場

Cell Signaling

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 246 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
細胞シグナル伝達の世界市場
出版日: 2023年03月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 246 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

細胞シグナル伝達の世界市場は2030年までに59億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に39億米ドルと推定される細胞シグナル伝達の世界市場は、2030年までに59億米ドルの改定規模に達し、2022年から2030年にかけてCAGR 5.5%で成長すると予測されます。本レポートで分析したセグメントの一つである消耗品は、CAGR6.1%を記録し、分析期間終了時には40億米ドルに達すると予測されます。パンデミック後の回復を考慮し、インストルメント分野の成長は、今後8年間のCAGRが4.2%に修正されました。

米国市場は12億米ドル、中国はCAGR5.1%の成長予測

米国の細胞シグナル伝達市場は、2022年に12億米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが5.1%で、2030年までに10億米ドルの市場規模に達すると予測されています。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ5.2%と4.3%の成長が予測されています。欧州では、ドイツがCAGR4.5%で成長すると予測されています。

調査対象企業の例

  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Merck KgaA
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP10950

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Cell Signaling Market to Reach $5.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Cell Signaling estimated at US$3.9 Billion in the year 2022, is projected to reach a revised size of US$5.9 Billion by 2030, growing at aCAGR of 5.5% over the period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 6.1% CAGR and reach US$4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 4.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 5.1% CAGR

The Cell Signaling market in the U.S. is estimated at US$1.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2030 trailing a CAGR of 5.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 4.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Select Competitors (Total 46 Featured) -

  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Merck KgaA
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Cell Signaling - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Endocrine Signaling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Endocrine Signaling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Paracrine Signaling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Paracrine Signaling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Autocrine Signaling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Autocrine Signaling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Juxtacrine Signaling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Juxtacrine Signaling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Microscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Western Blotting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Western Blotting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Flow Cytometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Immunohistochemistry (IHC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Immunohistochemistry (IHC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for ELISA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 22: World 8-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World 8-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World 8-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 27: World Recent Past, Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 28: World 8-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 29: World Cell Signaling Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Cell Signaling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 31: World 8-Year Perspective for Cell Signaling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: World 8-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 35: World 8-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Signaling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 36: USA Recent Past, Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 37: USA 8-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA 8-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 41: USA 8-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2023 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Cell Signaling by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 43: USA 8-Year Perspective for Cell Signaling by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada 8-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2023 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Canada 8-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Canada 8-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2023 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Cell Signaling by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Canada 8-Year Perspective for Cell Signaling by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
  • JAPAN
    • Cell Signaling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Japan 8-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2023 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Japan 8-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan 8-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2023 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Cell Signaling by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 59: Japan 8-Year Perspective for Cell Signaling by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
  • CHINA
    • Cell Signaling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 60: China Recent Past, Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 61: China 8-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2023 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China 8-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 65: China 8-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2023 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Cell Signaling by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 67: China 8-Year Perspective for Cell Signaling by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
  • EUROPE
    • Cell Signaling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe 8-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2023 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Europe 8-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 73: Europe 8-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2023 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Cell Signaling by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe 8-Year Perspective for Cell Signaling by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Cell Signaling by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 77: Europe 8-Year Perspective for Cell Signaling by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
  • FRANCE
    • Cell Signaling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 78: France Recent Past, Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 79: France 8-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2023 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France 8-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 83: France 8-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2023 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Cell Signaling by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 85: France 8-Year Perspective for Cell Signaling by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
  • GERMANY
    • Cell Signaling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany 8-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2023 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Germany 8-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Germany 8-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2023 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Cell Signaling by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Germany 8-Year Perspective for Cell Signaling by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
  • ITALY
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Italy 8-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2023 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Italy 8-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Italy 8-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2023 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Cell Signaling by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 101: Italy 8-Year Perspective for Cell Signaling by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
  • UNITED KINGDOM
    • Cell Signaling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 102: UK Recent Past, Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 103: UK 8-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2023 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UK 8-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 107: UK 8-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2023 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Cell Signaling by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 109: UK 8-Year Perspective for Cell Signaling by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 8-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2023 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 8-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 8-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2023 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Cell Signaling by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Rest of Europe 8-Year Perspective for Cell Signaling by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Cell Signaling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 8-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2023 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 8-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 8-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2023 & 2030
    • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Cell Signaling by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 125: Asia-Pacific 8-Year Perspective for Cell Signaling by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Cell Signaling by Type - Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 127: Rest of World 8-Year Perspective for Cell Signaling by Type - Percentage Breakdown of Value Sales for Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling and Other Types for the Years 2023 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Cell Signaling by Technology - Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of World 8-Year Perspective for Cell Signaling by Technology - Percentage Breakdown of Value Sales for Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), ELISA, Mass Spectrometry and Other Technologies for the Years 2023 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Cell Signaling by Application - Research and Medical - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 131: Rest of World 8-Year Perspective for Cell Signaling by Application - Percentage Breakdown of Value Sales for Research and Medical for the Years 2023 & 2030
    • TABLE 132: Rest of World Recent Past, Current & Future Analysis for Cell Signaling by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 133: Rest of World 8-Year Perspective for Cell Signaling by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030

IV. COMPETITION